FUJIFILM Diosynth Biotechnologies

Company Snapshot

Founded: 2011
Entity Type: Private
Employees: 4,800
Region: U.S.
Headquarter: North Carolina, U.S.
Key Geographics: North America, Europe, Asia-Pacific
Corporate Address: 101 J Morris Commons Lane Morrisville, North Carolina 27560 U.S. Tel. +1-919-337-4400 https: //fujifilmbiotechnologies.fujifilm.com/

Company Overview

FUJIFILM Diosynth Biotechnologies, frequently referred to simply as Diosynth, is a biopharmaceutical contract manufacturing company that creates manufacturing procedures, produces active ingredients and offers pharmaceutical companies fill and finish services. FUJIFILM Diosynth Biotechnologies has production sites in Morrisville, North Carolina; College Station, Texas; Teesside, United Kingdom; and Hillerod, Denmark in the United States and Europe; it also recently added locations in Thousand Oaks, California and Watertown, Massachusetts.

FUJIFILM Diosynth Biotechnologies In Reports

Global Viral Vector Manufacturing Markets and Technologies Through 2030

According to BCC Research detailed report on the viral vector manufacturing market data will be provided for 2024 because of the base year, with forecasts for 2025 and forecast value for 2030.

Global Market Opportunities and Competitive Landscape for CDMO

BCC Research Report: Dive into the contract development and manufacturing organization (CDMO) market analyzed to determine present and future market status, as well as forecasted growth from 2024 to 2029.

Biologics Contract Development and Manufacturing Organizations (CDMOs): Global Markets

BCC Research Market Report says global market for biologics CDMOs is expected to increase from $15.1 billion in 2023 to $27.0 billion by the end of 2028, with a CAGR of 12.3%.

Company's Business Segments

  • Biopharmaceutical Products and Services : The company offers services for the development and manufacturing of biopharmaceuticals, vaccines, and advanced therapies.

Applications/End User Industries

  • Biopharmaceutical
  • Healthcare
AI Sentiment